VT-30

N/A

Report date: 2022/08/05 20:00:43
NME

Base Information

Drug NameVT-30
Drug Alias NameVT-30BBP-681
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase alpha inhibitors
TargetsPhosphatidylinositol 3 kinase alpha
Therapy Area/IndicationsLymphatic AbnormalitiesArteriovenous MalformationsVascular Malformations
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVenthera Inc
China Registration ClassN/A

Develop Information

Active CompaniesBridgebio Pharma Inc
Inactive CompaniesVenthera Inc
Active IndicationsLymphatic AbnormalitiesArteriovenous Malformations
Inactive IndicationsVascular Malformations

Other Information

ATC CodeN/A
Related LinksN/A